Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

9-cis-Retinyl acetate

EU orphan designation number: EU/3/11/861   
Active ingredient: 9-cis-Retinyl acetate
Indication: Treatment of Leber's congenital amaurosis
Sponsor: QLT Ophthalmics (UK), Ltd
3 More London Riverside, London SE1 2AQ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/05/2011 Orphan designation EMA/OD/163/10 (2011)3487 of 13/05/2011
18/11/2011 Transfer of orphan designation EMA/OD/163/10/T/01 (2011)8534 of 16/11/2011
8/04/2019 Change of name and/or address of sponsor